India mandated prescriptions for syrup-based medicines to restore confidence after cough syrup contamination caused over 300 child deaths globally. However, the author argues this measure is defensive, not reformist, failing to address the root causes: manufacturing quality control, raw material testing, and regulatory oversight failures. While prescriptions may reduce inappropriate use, they won't prevent contaminated products. The government tolerates the pharma lobby's resistance to stringent testing, and understaffed drug controllers hinder enforcement. This subpar enforcement is dangerous for a nation aspiring to be the "world's pharmacy," undermining global health safety.